- In June 2024, Akums Drugs & Pharmaceuticals (India) introduced a chewable antacid tablet containing sodium alginate and potassium bicarbonate targeting GERD-induced laryngeal irritation. This OTC formulation aims to help reduce reflux-triggered laryngitis by forming a protective barrier in the throat
- In May 2024, AI-Powered Voice Diagnostic Model Published Researchers published an AI-driven voice analysis model capable of distinguishing healthy voices from those affected by laryngeal diseases, including cancer and vocal paralysis. The model demonstrated 85–97% accuracy in distinguishing healthy vs. diseased voices and is a promising step toward non-invasive, real-time laryngitis diagnostics
- In April 2024, AAO-HNS Updates Clinical Guideline on Hoarseness (Dysphonia)
The American Academy of Otolaryngology–Head and Neck Surgery released updated practice guidelines for persistent hoarseness (dysphonia). The revisions include new recommendations for timely referral to laryngoscopy, standardized diagnostic procedures, and voice-rest protocols—enhancing early detection and management of laryngitis
